After years of failure, ViaCyte shows off first proof-of-concept for diabetes stem cell transplants

Jason Mast

Editor

Seven years after they first tried it, ViaCyte finally has data showing that their stem cell treatment for diabetes — a potential cure — can work in …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

After years of failure, ViaCyte shows off first proof-of-concept for diabetes stem cell transplants

Jason Mast

Editor

Sign up to read this article for free.

Global Head of Marketing

Bachem

Bubendorf, BL, Switzerland

CBER's deputy director departs as staff shakeup continues

Bluebird bio to sell to investment funds after struggling to make money from gene therapies

FDA approves first drug to treat ultra-rare lipid storage disease

Eli Lilly stockpiles $548M of oral weight loss drug ahead of launch

FDA says Ozempic, Wegovy shortage is over

Trusted protection: Why the current meningococcal vaccination schedule shouldn’t change without strong evidence

Af­ter years of fail­ure, Vi­a­Cyte shows off first proof-of-con­cept for di­a­betes stem cell trans­plants

Editor

Sign up to read this article for free.

Bachem

Bubendorf, BL, Switzerland

After years of failure, ViaCyte shows off first proof-of-concept for diabetes stem cell transplants